Derrick Sung - 01 Dec 2025 Form 4 Insider Report for Pulmonx Corp (LUNG)

Signature
/s/ David Aaron Lehman, Attorney-in-Fact
Issuer symbol
LUNG
Transactions as of
01 Dec 2025
Net transactions value
$0
Form type
4
Filing time
03 Dec 2025, 19:45:52 UTC
Previous filing
10 Nov 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Sung Derrick COO and CFO C/O PULMONX CORPORATION, 700 CHESAPEAKE DRIVE, REDWOOD CITY /s/ David Aaron Lehman, Attorney-in-Fact 02 Dec 2025 0001670118

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUNG Common Stock Award $0 +1,200,000 +887% $0.000000 1,335,319 01 Dec 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LUNG Performance Stock Units Award $0 +400,000 $0.000000 400,000 01 Dec 2025 Common Stock 400,000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents grant of Restricted Stock Units payable solely in common stock of the Issuer, 25% of which vests one year from the grant date of December 1, 2025, and the remainder vests in equal quarterly installments over the three-year period following the date of grant.
F2 Each Performance Stock Unit represents a contingent right to receive one share of the Issuer's common stock. The Performance Stock Units vest upon meeting the following two conditions: (a) upon the Issuer's common stock achieving a specified price per share and (b) with respect to 33% on the one year following the grant date of December 1, 2025 and the remainder in eight equal quarterly installments.